Weight loss drugs like Ozempic (semaglutide) and Wegovy have become increasingly popular in 2024, with more patients relying on them to manage their weight, treat diabetes, and prevent heart attacks and strokes. However, experts also caution that these medications come with concerns, including high costs, side effects, and limitations.
According to Dr. Jody Dushay, an assistant professor of medicine at Harvard Medical School, about one in eight US adults have taken GLP-1 medications like Ozempic and Wegovy. These drugs work by reducing cravings and helping people feel fuller for longer, making it easier to stick to a diet. However, not everyone responds to the medication, with around 10% of patients showing no improvement.
Common side effects include nausea, vomiting, constipation, diarrhea, fatigue, and reflux. The high cost of these medications poses a significant challenge for access, with Medicare only covering them for secondary prevention of cardiovascular disease, excluding weight loss treatment. Private insurance often denies coverage or requires patients to try other medications before considering Ozempic or Wegovy.
Experts argue that while these medications can be effective, they should not replace proper nutrition and exercise in the fight against obesity. Instead, they should be used as part of a comprehensive program that includes lifestyle counseling. Dr. Dushay emphasizes the importance of understanding the limitations and potential side effects of these medications and using them judiciously.
As the demand for weight loss drugs like Ozempic and Wegovy continues to rise, it’s essential to consider their benefits and drawbacks, as well as the broader implications for healthcare and public policy.
Source: https://www.pbs.org/newshour/show/as-weight-loss-drug-demand-soars-physician-outlines-effectiveness-and-potential-downsides